Selected research
Industry Growth & Trends
Global Digestive System Antacids Industry Growth and Trends Forecast to 2032
Market perspective
The global Digestive System Antacids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Digestive System Antacids include Huasen Pharma, Takeda Pharmaceutical, Sanofi, Pfizer, CR SANJIU, GlaxoSmithKline, Bayer, AstraZeneca and Reddy'sLaboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Digestive System Antacids market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Digestive System Antacids market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Digestive System Antacids market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Digestive System Antacids.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Digestive System Antacids market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Digestive System Antacids Market by Company
Huasen Pharma
Takeda Pharmaceutical
Sanofi
Pfizer
CR SANJIU
GlaxoSmithKline
Bayer
AstraZeneca
Reddy'sLaboratories
Reckitt Benckiser
Procter&Gamble
Johnson&Johnson
CONBA
Bausch Health
Almirall
Digestive System Antacids Segment by Type
Sodium Bicarbonate Tablets
Magnesium Aluminum Carbonate Tablets
Aluminum Phosphate Gel
Compound Aluminum Hydroxide Tablets
Other
Digestive System Antacids Segment by Application
OTC Drug
Rx Drug
Digestive System Antacids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive System Antacids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digestive System Antacids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive System Antacids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digestive System Antacids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Digestive System Antacids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sodium Bicarbonate Tablets
- Magnesium Aluminum Carbonate Tablets
- Aluminum Phosphate Gel
- Compound Aluminum Hydroxide Tablets
- Other
Applications
- OTC Drug
- Rx Drug
Companies covered
- Huasen Pharma
- Takeda Pharmaceutical
- Sanofi
- Pfizer
- CR SANJIU
- GlaxoSmithKline
- Bayer
- AstraZeneca
- Reddy'sLaboratories
- Reckitt Benckiser
- Procter&Gamble
- Johnson&Johnson
- CONBA
- Bausch Health
- Almirall
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Digestive System Antacids Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Digestive System Antacids Sales Estimates and Forecasts (2021-2032)
- 1.3 Digestive System Antacids Market by Type
- 1.3.1 Sodium Bicarbonate Tablets
- 1.3.2 Magnesium Aluminum Carbonate Tablets
- 1.3.3 Aluminum Phosphate Gel
- 1.3.4 Compound Aluminum Hydroxide Tablets
- 1.3.5 Other
- 1.4 Global Digestive System Antacids Market Size by Type
- 1.4.1 Global Digestive System Antacids Market Size Overview by Type (2021-2032)
- 1.4.2 Global Digestive System Antacids Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Digestive System Antacids Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Digestive System Antacids Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Digestive System Antacids Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Digestive System Antacids Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Digestive System Antacids Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Digestive System Antacids Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Digestive System Antacids Industry Trends
- 2.2 Digestive System Antacids Industry Drivers
- 2.3 Digestive System Antacids Industry Opportunities and Challenges
- 2.4 Digestive System Antacids Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Digestive System Antacids Revenue (2021-2026)
- 3.2 Global Top Players by Digestive System Antacids Sales (2021-2026)
- 3.3 Global Top Players by Digestive System Antacids Price (2021-2026)
- 3.4 Global Digestive System Antacids Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Digestive System Antacids Major Company Production Sites & Headquarters
- 3.6 Global Digestive System Antacids Company, Product Type & Application
- 3.7 Global Digestive System Antacids Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Digestive System Antacids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Digestive System Antacids Players Market Share by Revenue in 2025
- 3.8.3 2025 Digestive System Antacids Tier 1, Tier 2, and Tier 3
4 Digestive System Antacids Regional Status and Outlook
- 4.1 Global Digestive System Antacids Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Digestive System Antacids Historic Market Size by Region
- 4.2.1 Global Digestive System Antacids Sales in Volume by Region (2021-2026)
- 4.2.2 Global Digestive System Antacids Sales in Value by Region (2021-2026)
- 4.2.3 Global Digestive System Antacids Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Digestive System Antacids Forecasted Market Size by Region
- 4.3.1 Global Digestive System Antacids Sales in Volume by Region (2027-2032)
- 4.3.2 Global Digestive System Antacids Sales in Value by Region (2027-2032)
- 4.3.3 Global Digestive System Antacids Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Digestive System Antacids by Application
- 5.1 Digestive System Antacids Market by Application
- 5.1.1 OTC Drug
- 5.1.2 Rx Drug
- 5.2 Global Digestive System Antacids Market Size by Application
- 5.2.1 Global Digestive System Antacids Market Size Overview by Application (2021-2032)
- 5.2.2 Global Digestive System Antacids Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Digestive System Antacids Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Digestive System Antacids Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Digestive System Antacids Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Digestive System Antacids Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Digestive System Antacids Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Digestive System Antacids Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Huasen Pharma
- 6.1.1 Huasen Pharma Company Information
- 6.1.2 Huasen Pharma Business Overview
- 6.1.3 Huasen Pharma Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Huasen Pharma Digestive System Antacids Product Portfolio
- 6.1.5 Huasen Pharma Recent Developments
- 6.2 Takeda Pharmaceutical
- 6.2.1 Takeda Pharmaceutical Company Information
- 6.2.2 Takeda Pharmaceutical Business Overview
- 6.2.3 Takeda Pharmaceutical Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Takeda Pharmaceutical Digestive System Antacids Product Portfolio
- 6.2.5 Takeda Pharmaceutical Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sanofi Digestive System Antacids Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Digestive System Antacids Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 CR SANJIU
- 6.5.1 CR SANJIU Company Information
- 6.5.2 CR SANJIU Business Overview
- 6.5.3 CR SANJIU Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 CR SANJIU Digestive System Antacids Product Portfolio
- 6.5.5 CR SANJIU Recent Developments
- 6.6 GlaxoSmithKline
- 6.6.1 GlaxoSmithKline Company Information
- 6.6.2 GlaxoSmithKline Business Overview
- 6.6.3 GlaxoSmithKline Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 GlaxoSmithKline Digestive System Antacids Product Portfolio
- 6.6.5 GlaxoSmithKline Recent Developments
- 6.7 Bayer
- 6.7.1 Bayer Company Information
- 6.7.2 Bayer Business Overview
- 6.7.3 Bayer Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Bayer Digestive System Antacids Product Portfolio
- 6.7.5 Bayer Recent Developments
- 6.8 AstraZeneca
- 6.8.1 AstraZeneca Company Information
- 6.8.2 AstraZeneca Business Overview
- 6.8.3 AstraZeneca Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 AstraZeneca Digestive System Antacids Product Portfolio
- 6.8.5 AstraZeneca Recent Developments
- 6.9 Reddy'sLaboratories
- 6.9.1 Reddy'sLaboratories Company Information
- 6.9.2 Reddy'sLaboratories Business Overview
- 6.9.3 Reddy'sLaboratories Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Reddy'sLaboratories Digestive System Antacids Product Portfolio
- 6.9.5 Reddy'sLaboratories Recent Developments
- 6.10 Reckitt Benckiser
- 6.10.1 Reckitt Benckiser Company Information
- 6.10.2 Reckitt Benckiser Business Overview
- 6.10.3 Reckitt Benckiser Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Reckitt Benckiser Digestive System Antacids Product Portfolio
- 6.10.5 Reckitt Benckiser Recent Developments
- 6.11 Procter&Gamble
- 6.11.1 Procter&Gamble Company Information
- 6.11.2 Procter&Gamble Business Overview
- 6.11.3 Procter&Gamble Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Procter&Gamble Digestive System Antacids Product Portfolio
- 6.11.5 Procter&Gamble Recent Developments
- 6.12 Johnson&Johnson
- 6.12.1 Johnson&Johnson Company Information
- 6.12.2 Johnson&Johnson Business Overview
- 6.12.3 Johnson&Johnson Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Johnson&Johnson Digestive System Antacids Product Portfolio
- 6.12.5 Johnson&Johnson Recent Developments
- 6.13 CONBA
- 6.13.1 CONBA Company Information
- 6.13.2 CONBA Business Overview
- 6.13.3 CONBA Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 CONBA Digestive System Antacids Product Portfolio
- 6.13.5 CONBA Recent Developments
- 6.14 Bausch Health
- 6.14.1 Bausch Health Company Information
- 6.14.2 Bausch Health Business Overview
- 6.14.3 Bausch Health Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Bausch Health Digestive System Antacids Product Portfolio
- 6.14.5 Bausch Health Recent Developments
- 6.15 Almirall
- 6.15.1 Almirall Company Information
- 6.15.2 Almirall Business Overview
- 6.15.3 Almirall Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Almirall Digestive System Antacids Product Portfolio
- 6.15.5 Almirall Recent Developments
7 North America by Country
- 7.1 North America Digestive System Antacids Sales by Country
- 7.1.1 North America Digestive System Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Digestive System Antacids Sales by Country (2021-2026)
- 7.1.3 North America Digestive System Antacids Sales Forecast by Country (2027-2032)
- 7.2 North America Digestive System Antacids Market Size by Country
- 7.2.1 North America Digestive System Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Digestive System Antacids Market Size by Country (2021-2026)
- 7.2.3 North America Digestive System Antacids Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Digestive System Antacids Sales by Country
- 8.1.1 Europe Digestive System Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Digestive System Antacids Sales by Country (2021-2026)
- 8.1.3 Europe Digestive System Antacids Sales Forecast by Country (2027-2032)
- 8.2 Europe Digestive System Antacids Market Size by Country
- 8.2.1 Europe Digestive System Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Digestive System Antacids Market Size by Country (2021-2026)
- 8.2.3 Europe Digestive System Antacids Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Digestive System Antacids Sales by Country
- 9.1.1 Asia-Pacific Digestive System Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Digestive System Antacids Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Digestive System Antacids Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Digestive System Antacids Market Size by Country
- 9.2.1 Asia-Pacific Digestive System Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Digestive System Antacids Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Digestive System Antacids Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Digestive System Antacids Sales by Country
- 10.1.1 South America Digestive System Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Digestive System Antacids Sales by Country (2021-2026)
- 10.1.3 South America Digestive System Antacids Sales Forecast by Country (2027-2032)
- 10.2 South America Digestive System Antacids Market Size by Country
- 10.2.1 South America Digestive System Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Digestive System Antacids Market Size by Country (2021-2026)
- 10.2.3 South America Digestive System Antacids Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Digestive System Antacids Sales by Country
- 11.1.1 Middle East and Africa Digestive System Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Digestive System Antacids Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Digestive System Antacids Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Digestive System Antacids Market Size by Country
- 11.2.1 Middle East and Africa Digestive System Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Digestive System Antacids Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Digestive System Antacids Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Digestive System Antacids Value Chain Analysis
- 12.1.1 Digestive System Antacids Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Digestive System Antacids Production Mode & Process
- 12.2 Digestive System Antacids Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Digestive System Antacids Distributors
- 12.2.3 Digestive System Antacids Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst